Related Experiment Video

Updated: Jun 8, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Targeted therapy for advanced thymic tumors

Arun Rajan1, Giuseppe Giaccone

  • 1Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|September 23, 2010
PubMed

Insights

Targeted therapies show limited success in thymic malignancies due to insufficient patient selection and small study sizes. Further research into tumor biology is crucial for advancing treatment strategies.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Targeted therapies are being explored for thymic malignancies.
  • Limited clinical trial data exists for these treatments.

Purpose of the Study:

  • To review the current evidence for targeted and biologic therapies in thymic malignancies.
  • To identify challenges and future directions for treatment development.

Main Methods:

  • Literature review of existing studies on targeted therapies for thymic malignancies.
  • Analysis of reported clinical trial data, case reports, and case series.

Main Results:

  • Few targeted therapies have been evaluated in Phase II trials.
  • Evidence primarily consists of case reports and small series.
  • No significant activity observed with current agents, likely due to poor patient selection and small sample sizes.

Conclusions:

  • Current targeted therapies have shown limited efficacy in thymic malignancies.
  • Improved patient selection and larger studies are needed.
  • A deeper understanding of thymic tumor biology is essential for future therapeutic advancements.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...